Literature DB >> 6718935

Inciting and etiologic agents of colitis.

J Silva, R Fekety, C Werk, J Ebright, M Cudmore, D Batts, C Syrjamaki, J Lukens.   

Abstract

Since 1979, 3,115 stool samples were tested for detection of Clostridium difficile and its cytotoxin; these were obtained from patients who had drug-related diarrhea. Presumed or proven colitis due to C. difficile was diagnosed in 130 patients. Drugs implicated most commonly as causing or associated with the onset of enterocolitis due to C. difficile were ampicillin (38 episodes), cephalosporins (71), clindamycin (36), and the aminoglycosides (45). The hamster model of colitis was employed to explore the role of other inducing agents. Altering the usual diet of hamsters to one with a higher protein content decreased the time to death due to C. difficile cecitis following the administration of cefazolin (10 mg). Several cathartics also were studied for their effect on the lethality of antibiotic-induced cecitis. Daily administrations of castor oil (0.5 ml per day) and vegetable oil (1.0 ml per day) improved survival against lethal doses of clindamycin. Milk of magnesia or mineral oil provided no protection. Four patients with C. difficile colitis induced by therapy with cytotoxic drugs also were identified. Methotrexate induced cecitis when administered orally and daily to hamsters, and C. difficile and its cytotoxin were identified in the hamsters' stools. Death due to methotrexate-induced cecitis was prevented by daily administration of folinic acid or vancomycin. These data demonstrate that a variety of antibiotics, antineoplastic agents, cathartics, and diet changes can induce C. difficile colitis in humans and hamsters.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6718935     DOI: 10.1093/clinids/6.supplement_1.s214

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  10 in total

1.  Effects of antibiotics and other drugs on toxin production in Clostridium difficile in vitro and in vivo.

Authors:  M C Barc; C Depitre; G Corthier; A Collignon; W J Su; P Bourlioux
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

Review 2.  Drug-induced Clostridium difficile-associated disease.

Authors:  M L Job; N F Jacobs
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

3.  An epidemiologic postmarketing surveillance study of prescription acne medications.

Authors:  D P Facklam; J S Gardner; G L Neidert; M M Westland
Journal:  Am J Public Health       Date:  1990-01       Impact factor: 9.308

Review 4.  Update on pseudomembranous colitis.

Authors:  J Silva
Journal:  West J Med       Date:  1989-12

5.  The impact of Clostridium difficile on a surgical service: a prospective study of 374 patients.

Authors:  K C Kent; M S Rubin; L Wroblewski; P A Hanff; W Silen
Journal:  Ann Surg       Date:  1998-02       Impact factor: 12.969

Review 6.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

Review 7.  Models for the study of Clostridium difficile infection.

Authors:  Emma L Best; Jane Freeman; Mark H Wilcox
Journal:  Gut Microbes       Date:  2012-03-01

8.  Factors influencing the phagocytosis of Clostridium difficile by human polymorphonuclear leukocytes.

Authors:  D C Dailey; A Kaiser; R H Schloemer
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

9.  Cloning and expression of secreted antigens of Clostridium difficile in Escherichia coli.

Authors:  D C Dailey; R H Schloemer
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

10.  Hydrophobic and adherence properties of Clostridium difficile.

Authors:  S J Wood-Helie; H P Dalton; S Shadomy
Journal:  Eur J Clin Microbiol       Date:  1986-08       Impact factor: 3.267

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.